Allucent

Founded in 1984, Rho provides services for clinical trial research throughout the world and serves the pharmaceutical and biotechnology industries. The company s clinical trial information management services include clinical data management consulting, query management and data processing. Its medical writing products include clinical trial protocols and amendments, investigator brochures, study procedure manuals, interim data summaries, safety narratives, clinical study reports and journal articles. The company also features various project management services, such as flexible communication and project planning, execution, control and closure. In addition, Rho offers a range of clinical monitoring services, including investigator identification and selection, regulatory document reviewing and collection, interim site monitoring and on-site training.

Vascular Biosciences is a biotech company based in Durham, NC, specializing in the development of innovative solutions for hard-to-treat diseases. Their product portfolio includes CAR peptide technology, co-administered therapeutics, and molecular diagnostics, with applications ranging from pulmonary hypertension and sepsis to gene therapy and lung cancer. With a focus on interventional medicine, Vascular Biosciences offers advanced technologies such as the endoarterial biopsy catheter, designed to facilitate precise diagnostic procedures. The company actively seeks collaborations with physicians, scientists, and researchers to drive innovation in the field and welcomes investment opportunities to further their mission of addressing unmet medical needs.Generated from the website

Evecxia Therapeutics, Inc., based in Durham, NC, is a pioneering pharmaceutical company dedicated to improving the lives of individuals with mental illness. With a focus on serotonin synthesis amplification, Evecxia is at the forefront of developing innovative drug delivery technologies to harness the therapeutic potential of 5-hydroxytryptamine (5-HTP), the natural precursor of serotonin. By amplifying the production of natural brain serotonin, Evecxia aims to provide more effective treatment options for individuals suffering from mental illnesses that are not adequately addressed by current therapies. Driven by the mission to help individuals lead fuller and more meaningful lives, Evecxia Therapeutics is committed to addressing the negative impact of mental illness on various aspects of life, including emotional well-being, work performance, and relationships. By leveraging their expertise in serotonin neurotransmission, Evecxia is developing novel drug candidates that have shown promise in clinical settings, particularly as adjunctive therapies for depression. Through their innovative approach, Evecxia Therapeutics aims to revolutionize the treatment of mental illnesses and provide new hope for those in need.Generated from the website